Cisplatin triggers apoptotic or nonapoptotic cell death in Fanconi anemia lymphoblasts in a concentration-dependent manner

Experimental Cell Research

Volumn 286, Issue 2, 2003, Pages 381-395

  Ferrer, Miriam ^a   Izeboud, Thijs ^a   Ferreira, Carlos G ^a,b   Span, Simone W ^a   Giaccone, Giuseppe ^a   Kruyt, Frank A E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Apoptosis; Bax, Cisplatin; Caspases; Fanconi anemia; Lymphoblasts; PCD

Indexed keywords

CASPASE; CISPLATIN; DNA FRAGMENT; PHOSPHATIDYLSERINE; PROTEIN BAX;

APOPTOSIS; ARTICLE; CELL DEATH; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; ENZYME ACTIVITY; FANCONI ANEMIA; HUMAN; HUMAN CELL; LIPID DEGRADATION; LYMPHOBLAST; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037960137     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00112-5     Document Type: Article

References (67)

1. Fanconi G. Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.). I. Clinical aspects. Semin. Hematol. 4:1967;233-240.
2. Butturini A., Gale R.P., Verlander P.C., Adler-Brecher B., Gillio A.P., Auerbach A.D. Hematologic abnormalities in Fanconi anemia an International Fanconi Anemia Registry study . Blood. 84:1994;1650-1655.
3. Strathdee C.A., Duncan A.M., Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nature Genet. 1:1992;196-198.
4. Lo Ten Foe J.R., Rooimans M.A., Bosnoyan-Collins L., Alon N., Wijker M., Parker L., Lightfoot J., Carreau M., Callen D.F., Savoia A., Cheng N.C., van Berkel C.G., Strunk M.H., Gille J.J., Pals G., Kruyt F.A., Pronk J.C., Arwert F., Buchwald M., Joenje H. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nature Genet. 14:1996;320-323.
5. Joenje H., Levitus M., Waisfisz Q., D'Andrea A., Garcia-Higuera I., Pearson T., van Berkel C.G., Rooimans M.A., Morgan N., Mathew C.G., Arwert F. Complementation analysis in Fanconi anemia assignment of the reference FA-H patient to group A . Am. J. Hum. Genet. 67:2000;759-762.
6. The Fanconi anaemia/breast cancer consortium. Positional cloning of the Fanconi anaemia group A gene. Nature Genet. 14 (1996) 324-328.
7. de Winter J.P., Waisfisz Q., Rooimans M.A., van Berkel C.G., Bosnoyan-Collins L., Alon N., Carreau M., Bender O., Demuth I., Schindler D., Pronk J.C., Arwert F., Hoehn H., Digweed M., Buchwald M., Joenje H. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nature Genet. 20:1998;281-283.
8. de Winter J.P., Leveille F., van Berkel C.G., Rooimans M.A., van Der Weel L., Steltenpool J., Demuth I., Morgan N.V., Alon N., Bosnoyan-Collins L., Lightfoot J., Leegwater P.A., Waisfisz Q., Komatsu K., Arwert F., Pronk J.C., Mathew C.G., Digweed M., Buchwald M., Joenje H. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet. 67:2000;1306-1308.
9. de Winter J.P., Rooimans M.A., van Der Weel L., van Berkel C.G., Alon N., Bosnoyan-Collins L., de Groot J., Zhi Y., Waisfisz Q., Pronk J.C., Arwert F., Mathew C.G., Scheper R.J., Hoatlin M.E., Buchwald M., Joenje H. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nature Genet. 24:2000;15-16.
10. Timmers C., Taniguchi T., Hejna J., Reifsteck C., Lucas L., Bruun D., Thayer M., Cox B., Olson S., D'Andrea A.D., Moses R., Grompe M. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell. 7:2001;241-248.
11. Kupfer G.M., Naf D., D'Andrea A.D. Molecular biology of Fanconi anemia. Hematol. Oncol. Clin. North Am. 11:1997;1045-1060.
12. de Winter J.P., van der Weel L., de Groot J., Stone S., Waisfisz Q., Arwert F., Scheper R.J., Kruyt F.A., Hoatlin M.E., Joenje H. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9:2000;2665-2674.
13. Medhurst A.L., Huber P.A., Waisfisz Q., de Winter J.P., Mathew C.G. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum. Mol. Genet. 10:2001;423-429.
14. Ishida R., Buchwald M. Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents. Cancer Res. 42:1982;4000-4006.
15. Auerbach A.D., Rogatko A., Schroeder-Kurth T.M. International Fanconi Anemia Registry relation of clinical symptoms to diepoxybutane sensitivity . Blood. 73:1989;391-396.
16. Grompe M., D'Andrea A. Fanconi anemia and DNA repair. Hum. Mol. Genet. 10:2001;2253-2259.
17. Fagerlie S., Lensch M.W., Pang Q., Bagby G.C. Jr. The Fanconi anemia group C gene product signaling functions in hematopoietic cells . Exp. Hematol. 29:2001;1371-1381.
18. Cumming R.C., Lightfoot J., Beard K., Youssoufian H., O'Brien P.J., Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nature Med. 7:2001;814-820.
19. Guillouf C., Wang T.S., Liu J., Walsh C.E., Poirier G.G., Moustacchi E., Rosselli F. Fanconi anemia C protein acts at a switch between apoptosis and necrosis in mitomycin C-induced cell death. Exp. Cell Res. 246:1999;384-394.
20. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell. 7:2001;249-262.
21. Kruyt F.A., Hoshino T., Liu J.M., Joseph P., Jaiswal A.K., Youssoufian H. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood. 92:1998;3050-3056.
22. Hoshino T., Wang J., Devetten M.P., Iwata N., Kajigaya S., Wise R.J., Liu J.M., Youssoufian H. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression. Blood. 91:1998;4379-4386.
23. Hoatlin M.E., Zhi Y., Ball H., Silvey K., Melnick A., Stone S., Arai S., Hawe N., Owen G., Zelent A., Licht J.D. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood. 94:1999;3737-3747.
24. Rathbun R.K., Christianson T.A., Faulkner G.R., Jones G., Keeble W., O'Dwyer M., Bagby G.C. Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members. Blood. 96:2000;4204-4211.
25. Haneline L.S., Broxmeyer H.E., Cooper S., Hangoc G., Carreau M., Buchwald M., Clapp D.W. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. Blood. 91:1998;4092-4098.
26. Cumming R.C., Liu J.M., Youssoufian H., Buchwald M. Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene. Blood. 88:1996;4558-4567.
27. Pang Q., Keeble W., Christianson T.A., Faulkner G.R., Bagby G.C. FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity. EMBO J. 20:2001;4478-4489.
28. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases structure, activation, substrates, and functions during apoptosis . Annu. Rev. Biochem. 68:1999;383-424.
29. Thornberry N.A., Lazebnik Y. Caspases enemies within . Science. 281:1998;1312-1316.
30. Sun X.M., MacFarlane M., Zhuang J., Wolf B.B., Green D.R., Cohen G.M. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274:1999;5053-5060.
31. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
32. Zou H., Li Y., Liu X., Wang X. An APAF-1. cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274:1999;11549-11556.
33. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803-815.
34. Muzio M., Salvesen G.S., Dixit V.M. FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. J. Biol. Chem. 272:1997;2952-2956.
35. Reed J.C. Bc1-2 family proteins. Oncogene. 17:1998;3225-3236.
36. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
37. Kroemer G. The proto-oncogene Bc1-2 and its role in regulating apoptosis. Nature Med. 3:1997;614-620.
38. Adams J.M., Cory S. Life-or-death decisions by the Bc1-2 protein family. Trends Biochem. Sci. 26:2001;61-66.
39. Leist M., Jaattela M. Four deaths and a funeral from caspases to alternative mechanisms . Nature Rev. Mol. Cell. Biol. 2:2001;589-598.
40. Guillouf C., Vit J.P., Rosselli F. Loss of the Fanconi anemia group C protein activity results in an inability to activate caspase-3 after ionizing radiation. Biochimie. 82:2000;51-58.
41. Vit J.P., Guillouf C., Rosselli F. Futile caspase-8 activation during the apoptotic cell death induced by DNA damaging agents in human B-lymphoblasts. Exp. Cell Res. 269:2001;2-12.
42. Kruyt F.A., Dijkmans L.M., van den Berg T.K., Joenje H. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood. 87:1996;938-948.
43. Marathi U.K., Howell S.R., Ashmun R.A., Brent T.P. The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells. Blood. 88:1996;2298-2305.
44. Kruyt F.A., Youssoufian H. The Fanconi anemia proteins FAA and FAC function in different cellular compartments to protect against cross-linking agent cytotoxicity. Blood. 92:1998;2229-2236.
45. Fadok V.A., de Cathelineau A., Daleke D.L., Henson P.M., Bratton D.L. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J. Biol. Chem. 276:2001;1071-1077.
46. Hoffmann P.R., deCathelineau A.M., Ogden C.A., Leverrier Y., Bratton D.L., Daleke D.L., Ridley A.J., Fadok V.A., Henson P.M. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell Biol. 155:2001;649-660.
47. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
48. Tounekti O., Belehradek J. Jr., Mir L.M. Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis. Exp. Cell Res. 217:1995;506-516.
49. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
50. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347.
51. Slee E.A., Adrain C., Martin S.J. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 276:2001;7320-7326.
52. Adams J.M., Cory S. The Bc1-2 protein family arbiters of cell survival . Science. 281:1998;1322-1326.
53. Zunino A., Degan P., Vigo T., Abbondandolo A. Hydrogen peroxide effects on DNA, chromosomes, cell cycle and apoptosis induction in Fanconi's anemia cell lines . Mutagenesis. 16:2001;283-288.
54. Stennicke H.R., Deveraux Q.L., Humke E.W., Reed J.C., Dixit V.M., Salvesen G.S. Caspase-9 can be activated without proteolytic processing. J. Biol. Chem. 274:1999;8359-8362.
55. Renatus M., Stennicke H.R., Scott F.L., Liddington R.C., Salvesen G.S. Dimer formation drives the activation of the cell death protease caspase 9. Proc. Natl. Acad. Sci. USA. 98:2001;14250-14255.
56. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., Reed J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1998;1318-1321.
57. Ridet A., Guillouf C., Duchaud E., Cundari E., Fiore M., Moustacchi E., Rosselli F. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res. 57:1997;1722-1730.
58. Cahir-McFarland E.D., Davidson D.M., Schauer S.L., Duong J., Kieff E. NF- kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc. Natl. Acad. Sci. USA. 97:2000;6055-6060.
59. Thomas A., El Rouby S., Reed J.C., Krajewski S., Silber R., Potmesil M., Newcomb E.W. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia relationship between p53 gene mutation and bc1-2/bax proteins in drug resistance . Oncogene. 12:1996;1055-1062.
60. Gao G., Dou Q.P. N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bc1-2-independent cytochrome C release and apoptotic cell death. J. Cell. Biochem. 80:2000;53-72.
61. Schmitt E., Paquet C., Beauchemin M., Dever-Bertrand J., Bertrand R. Characterization of Bax-sigma, a cell death-inducing isoform of Bax. Biochem. Biophys. Res. Commun. 270:2000;868-879.
62. Pang Q., Christianson T.A., Keeble W., Diaz J., Faulkner G.R., Reifsteck C., Olson S., Bagby G.C. The Fanconi anemia complementation group C gene product structural evidence of multifunctionality . Blood. 98:2001;1392-1401.
63. Clarke A.A., Marsh J.C., Gordon-Smith E.C., Rutherford T.R. Molecular genetics and Fanconi anaemia new insights into old problems . Br. J. Haematol. 103:1998;287-296.
64. Buchwald M., Moustacchi E. Is Fanconi anemia caused by a defect in the processing of DNA damage? Mutat. Res. 408:1998;75-90.
65. Kruyt F.A., Youssoufian H. Do Fanconi anemia genes control cell response to cross-linking agents by modulating cytochrome P-450 reductase activity? Drug Resist. Update. 3:2000;211-215.
66. D'Andrea A.D. Cellular function of the Fanconi anemia pathway. Nature Med. 7:2001;1259-1260.
67. Kontou M., Adelfalk C., Ramirez M.H., Ruppitsch W., Hirsch-Kauffmann M., Schweiger M. Overexpressed thioredoxin compensates Fanconi anemia related chromosomal instability. Oncogene. 21:2002;2406-2412.